Williams v. The National Football League

495 F. App'x 894
CourtCourt of Appeals for the Tenth Circuit
DecidedAugust 27, 2012
Docket12-1255
StatusUnpublished

This text of 495 F. App'x 894 (Williams v. The National Football League) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Williams v. The National Football League, 495 F. App'x 894 (10th Cir. 2012).

Opinion

ORDER AND JUDGMENT *

PER CURIAM.

Genos “D.J.” Williams, a linebacker for the Denver Broncos, appeals from the district court’s order granting the National Football League’s (NFL’s) motion for summary judgment and denying as moot his motion for a preliminary injunction. We have jurisdiction under 28 U.S.C. § 1291, and we AFFIRM for substantially the same reasons identified by the district court.

Background

Pursuant to a collective bargaining agreement between the NFL Management Council and the NFL Players Association, the NFL has adopted a policy “prohibit[ing] the use of anabolic/androgenic steroids (including exogenous testosterone), stimulants, human or animal growth hormones, whether natural or synthetic, and related or similar substances.” ApltApp., Yol. I at 159. To enforce the policy, all players are tested at least once per league year. Moreover, players are randomly selected throughout the calendar year for testing. In addition to providing penalties for players who test positive, the policy also penalizes “[a]ny effort to substitute, dilute or adulterate a [urine] specimen, or to manipulate a test result to evade detection.” Id. at 163.

On August 9, 2011, pursuant to the NFL’s annual testing regimen, Mr. Williams provided a urine, specimen to a certified specimen collector at the Broncos’ training facility in Englewood, Colorado. Laboratory tests on the urine specimen showed “[n]o endogenous steroids,” a finding “inconsistent with a physiological urinary steroid profile.” Id. at 110. In other words, Mr. Williams’s “urine specimen had been determined not to be a human specimen.” Aplt. Br. at 10.

On September 7, 2011, Mr. Williams appeared before the same specimen collector and provided a urine specimen under the NFL’s random testing regimen. The results of that test likewise showed “[n]o endogenous steroids,” which is “inconsistent with a physiological urinary steroid profile.” ApltApp., Vol. I at 233.

Afterward, the National Center for Drug Free Sport, which oversees the NFL’s urine-specimen collection programs and engages collection companies to obtain the specimens from players, interviewed the specimen collector. He admitted that “at times [he] viewed from the side as opposed to full frontal.” Id. at 266. Because the collector failed to follow “standard protocols” in “the validation process,” the Center suspended him from further collections, and his employment was terminated by the collections contractor. Id. Later, the collector submitted an affidavit asserting that he “directly observed Mr. *896 Williams provide a urine sample.” Id., Vol. II at 486.

On November 11, 2011, the NFL announced that Mr. Williams was in violation of the NFL’s steroid policy based on the test results from his August 9 urine specimen. 1 As punishment, the NFL stated that he would be “suspended for six regular-season games,” “placed on reasonable cause testing for the remainder of [his] career,” “required to return 6/17 of any applicable signing bonus,” suspended for at least eight games upon another violation, and reinstated to play only upon the approval of the steroid policy’s administrator. Id., Vol. I at 66-67. Mr. Williams appealed the NFL’s decision to arbitration.

Prior to the arbitration hearing, on November 16, 2011, Mr. Williams appeared before a new collector and provided a urine specimen under the NFL’s Substances of Abuse program. While that specimen tested negative for controlled substances, the collector reported that during the collection process Mr. Williams “turned out of frontal view and a bottle fell to the floor.... [Mr. Williams] immediately kicked the bottle out of the restroom towards his locker and his personal belongings.” Id. at 288. The NFL did not discipline Mr. Williams for this incident, but instead issued a warning.

On December 13, 2011, the NFL held a hearing on Mr. Williams’s appeal. The arbitrator heard testimony from a number of witnesses concerning the NFL’s steroid policy and its implementation, and the collection and processing of Mr. Williams’s urine specimens. Mr. Williams testified it was his position that he “did not produce the [urine] specimens on August 9 or September 7.” Id. at 823. As to the November 16 incident, Mr. Williams maintained that the bottle was “something that [he] used for energy” before practice, and that his foot inadvertently struck it after it fell to the floor. Id. at 301 (internal quotation marks omitted). The hearing concluded after closing arguments.

On January 16, 2012, two days after the Broncos were eliminated from the playoffs in the postseason, counsel for Mr. Williams requested by email that the arbitrator dismiss the case because he had failed to render a decision within the timeframe contemplated by the steroid policy. See id. at 180 (stating that “the Hearing Officer will evaluate the evidence and render a written decision with respect to disciplinary action within five (5) calendar days”). The arbitrator declined by email on January 19, stating that he “was asked to delay a decision on this matter to afford an opportunity for the parties to the governing collective bargaining agreement, the NFL and the NFL[Players Association], to explore an agreed resolution of this dispute.” Id., Vol. II at 372. The arbitrator further stated that “[t]his action is consistent with past practice.” Id. The parties do not dispute that the arbitrator had communicated with the NFL’s general counsel and executive vice-president, Jeffrey Pash.

On February 6, the arbitrator rendered a decision denying Mr. Williams’s appeal. In reaching that result, he interpreted the steroid policy as placing “the burden ... on the [NFL] to establish that any departure from its stated protocols did not materially affect the validity of the violation.” Id. at 376. The arbitrator found it “clear that Williams was involved in three separate incidents of attempted substitution of a specimen.” Id. at 379. As for the August 9 urine specimen in particular, the arbitrator concluded that the integrity of the results was not in serious doubt:

*897 There is no break in the chain of custody which would materially affect the validity of the laboratory test....
... Only one person has been shown to have a motive to substitute the specimen; Williams[ ] is the only one with a lot at stake here, so I am persuaded of his culpability.
There is no direct evidence in this record about how the bogus urine was submitted as Mr. Williams’[s] specimen, but the circumstantial evidence compels the conclusion that the substitution occurred either with [the August 9 collector’s] knowledge or through his failure to comply with requirements of the collection protocols.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
495 F. App'x 894, Counsel Stack Legal Research, https://law.counselstack.com/opinion/williams-v-the-national-football-league-ca10-2012.